Q2
RVTY — Q2 2026 Financial Report Analysis
Revvity's Q2 2026 revenue rose 1% to $729.7M as Diagnostics grew 11% organically excluding a China business being sold, while tariff refunds and restructuring charges roughly cancelled out in GAAP profit; full-year guidance was raised.